002100 天康生物
2026/03 - 三个月2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)-2.3663.0189.013-19.0333.740
总资产报酬率 ROA (%)-0.9221.2053.527-7.5501.538
投入资产回报率 ROIC (%)-1.1271.4824.406-9.3891.832

边际利润分析
销售毛利率 (%)3.8629.86212.1422.92410.143
营业利润率 (%)-3.9571.8973.674-7.6001.512
息税前利润/营业总收入 (%)-3.2862.7474.456-6.8382.466
净利润/营业总收入 (%)-4.4041.7683.472-7.9701.118

收益指标分析
经营活动净收益/利润总额(%)87.155123.229113.99964.929153.436
价值变动净收益/利润总额(%)-0.50010.556-0.306-0.2328.245
营业外收支净额/利润总额(%)5.3141.798-3.3233.143-18.888

偿债能力分析
流动比率 (X)1.6341.5321.5161.2641.997
速动比率 (X)0.8240.6750.8090.6221.023
资产负债率 (%)53.21450.91451.49052.75250.265
带息债务/全部投入资本 (%)50.43747.83247.11947.74147.330
股东权益/带息债务 (%)92.263101.953104.891101.187106.038
股东权益/负债合计 (%)71.43678.39377.58172.54481.327
利息保障倍数 (X)-3.6823.3724.950-6.7782.064

营运能力分析
应收账款周转天数 (天)12.2289.6809.3337.6577.355
存货周转天数 (天)130.386119.469109.115103.269133.157